NLS Pharmaceutics AG
NLSP1.880USD
+0.080+4.44%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.860USD+1.860After-hours 08/04, 20:00 (ET)
5.94MMarket Cap
--P/E TTM
NLS Pharmaceutics AG
1.880
+0.080+4.44%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
Operating expenses
-62.82%1.58M
-72.80%2.05M
-37.34%4.26M
-13.10%7.55M
-7.15%6.79M
91.25%8.69M
--7.32M
--4.54M
R&D expenses
-90.12%150.70K
-93.81%271.35K
-55.58%1.52M
-20.93%4.38M
-15.39%3.43M
197.63%5.54M
--4.06M
--1.86M
Depreciation, depletion, and amortization
----
0.00%5.70K
0.00%5.70K
0.00%5.70K
13.44%5.70K
13.58%5.70K
--5.03K
--5.02K
Operating profit
62.82%-1.58M
72.80%-2.05M
37.34%-4.26M
13.10%-7.55M
7.15%-6.79M
-91.25%-8.69M
---7.32M
---4.54M
Net non-operating interest income (expenses)
Non-operating interest income
----
----
----
----
--10.04K
----
----
--7.54K
Non-operating interest expense
-56.54%63.03K
67330.23%86.98K
487.67%145.02K
-98.59%129.00
-0.76%24.68K
-65.39%9.18K
--24.87K
--26.52K
Gains from sale of securities
----
----
----
----
---67.01K
----
--0.00
---41.61K
Special income (expenses)
--1.76M
----
100.00%0.00
----
---922.50K
----
----
----
Other non-operating income (expenses)
64.71%-55.29K
265.77%104.64K
-177.83%-156.69K
-211.93%-63.13K
---56.40K
--56.40K
----
----
Income before tax
101.21%55.02K
73.26%-2.04M
41.96%-4.56M
11.90%-7.61M
-6.97%-7.85M
-87.71%-8.64M
---7.34M
---4.60M
Income after tax
101.21%55.02K
73.26%-2.04M
41.96%-4.56M
11.90%-7.61M
-6.97%-7.85M
-87.71%-8.64M
---7.34M
---4.60M
Net income from continuous operations
101.21%55.02K
73.26%-2.04M
41.96%-4.56M
11.90%-7.61M
-6.97%-7.85M
-87.71%-8.64M
---7.34M
---4.60M
Net income attributable to controlling interests
55.67%-2.02M
73.26%-2.04M
41.96%-4.56M
11.90%-7.61M
-6.97%-7.85M
-87.71%-8.64M
---7.34M
---4.60M
Preferred share dividend
--2.08M
----
----
----
----
----
----
----
Net income attributable to common shareholders
55.67%-2.02M
73.26%-2.04M
41.96%-4.56M
11.90%-7.61M
-6.97%-7.85M
-87.71%-8.64M
---7.34M
---4.60M
Basic earnings per share
79.24%-0.99
75.66%-1.94
64.31%-4.78
63.32%-7.98
41.97%-13.39
-30.74%-21.75
---23.06
---16.63
Diluted earnings per share
79.24%-0.99
75.66%-1.94
64.31%-4.78
63.32%-7.98
41.97%-13.39
-30.74%-21.75
---23.06
---16.63
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
